Literature DB >> 21055734

Preserved MHC-II antigen processing and presentation function in chronic HCV infection.

D H Canaday1, C J Burant, L Jones, H Aung, L Woc-Colburn, D D Anthony.   

Abstract

Individuals with chronic HCV infection have impaired response to vaccine, though the etiology remains to be elucidated. Dendritic cells (DC) and monocytes (MN) provide antigen uptake, processing, presentation, and costimulatory functions necessary to achieve optimal immune responses. The integrity of antigen processing and presentation function within these antigen presenting cells (APC) in the setting of HCV infection has been unclear. We used a novel T cell hybridoma system that specifically measures MHC-II antigen processing and presentation function of human APC. Results demonstrate MHC-II antigen processing and presentation function is preserved in both myeloid DC (mDC) and MN in the peripheral blood of chronically HCV-infected individuals, and indicates that an alteration in this function does not likely underlie the defective HCV-infected host response to vaccination. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21055734      PMCID: PMC3005840          DOI: 10.1016/j.cellimm.2010.10.003

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  30 in total

1.  Class II MHC antigen presentation defect in neonatal monocytes is not correlated with decreased MHC-II expression.

Authors:  David H Canaday; Soma Chakravarti; Tarun Srivastava; Daniel J Tisch; Vinay K Cheruvu; Jamie Smialek; Clifford V Harding; Lakshmi Ramachandra
Journal:  Cell Immunol       Date:  2007-02-26       Impact factor: 4.868

2.  Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes.

Authors:  Angela Dolganiuc; Edward Paek; Karen Kodys; Joanne Thomas; Gyongyi Szabo
Journal:  Gastroenterology       Date:  2008-08-07       Impact factor: 22.682

Review 3.  Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination.

Authors:  Emmet B Keeffe
Journal:  Am J Med       Date:  2005-10       Impact factor: 4.965

4.  Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients.

Authors:  Ian Gaël Rodrigue-Gervais; Loubna Jouan; Geneviève Beaulé; Dominike Sauvé; Julie Bruneau; Bernard Willems; Rafick-Pierre Sékaly; Daniel Lamarre
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

5.  TLR ligand-dependent activation of naive CD4 T cells by plasmacytoid dendritic cells is impaired in hepatitis C virus infection.

Authors:  Nicole L Yonkers; Benigno Rodriguez; Kimberly A Milkovich; Robert Asaad; Michael M Lederman; Peter S Heeger; Donald D Anthony
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

6.  Accumulation of dysfunctional effector CD8+ T cells in the liver of patients with chronic HCV infection.

Authors:  Carla Nisii; Massimo Tempestilli; Chiara Agrati; Fabrizio Poccia; Guido Tocci; Maria Antonella Longo; Gianpiero D'Offizi; Roberto Tersigni; Oreste Lo Iacono; Giorgio Antonucci; Alessandra Oliva
Journal:  J Hepatol       Date:  2005-12-05       Impact factor: 25.083

Review 7.  Global epidemiology of hepatitis C virus infection.

Authors:  Colin W Shepard; Lyn Finelli; Miriam J Alter
Journal:  Lancet Infect Dis       Date:  2005-09       Impact factor: 25.071

Review 8.  Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review.

Authors:  Abdel Aziz M Shaheen; Robert P Myers
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

9.  Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection.

Authors:  Donald D Anthony; Nicole L Yonkers; Anthony B Post; Robert Asaad; Frederick P Heinzel; Michael M Lederman; Paul V Lehmann; Hernan Valdez
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

10.  Rapid MHC-II antigen presentation of HIV type 1 by human dendritic cells.

Authors:  Leola Jones; David McDonald; David H Canaday
Journal:  AIDS Res Hum Retroviruses       Date:  2007-06       Impact factor: 2.205

View more
  5 in total

1.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

Review 2.  Dendritic cell-based immunity and vaccination against hepatitis C virus infection.

Authors:  Yun Zhou; Ying Zhang; Zhiqiang Yao; Jonathan Patrick Moorman; Zhansheng Jia
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

3.  Production of CD4⁺ and CD8⁺ T cell hybridomas.

Authors:  David H Canaday
Journal:  Methods Mol Biol       Date:  2013

Review 4.  Dendritic cells in hepatitis C infection: can they (help) win the battle?

Authors:  Angela Dolganiuc; Gyongyi Szabo
Journal:  J Gastroenterol       Date:  2011-02-17       Impact factor: 6.772

Review 5.  Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C.

Authors:  Phyllis T Losikoff; Alyssa A Self; Stephen H Gregory
Journal:  Virulence       Date:  2012-10-17       Impact factor: 5.882

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.